Status:
UNKNOWN
Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The efficacy of vaccination against influenza in patients with rheumatoid arthritis has been assessed using humoral response. However, the cellular immunity is another important pathway of response to...
Detailed Description
Sixty patients with RA and 30 healthy , aged matched controls will participate in the study. After signing informed consent, all subjects will be vaccinated with the inactivated split virion vaccine ...
Eligibility Criteria
Inclusion
- Rheumatoid arthritis
Exclusion
- Allergy to egg
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01002716
Start Date
October 1 2009
End Date
April 1 2010
Last Update
October 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Medical Center
Tel Aviv, Israel, 64239